Michael Fenn
Advisor at Harmonix Fund
About
Michael Fenn is Director of External Innovation at Dewpoint Therapeutics and previously served as Director of Healthcare & Life Sciences at Harvard Innovation Labs, where he co-led planning of Life Lab Longwood at Harvard Medical School. He was formerly an Assistant Professor of Biomedical Engineering and Director of the Center for Medical Materials & Biophotonics at the Florida Institute of Technology. He holds a Ph.D. in Biomedical Engineering, an M.S. in Materials Science and Engineering, and a B.S. in Chemistry/Biochemistry, all from the University of Florida, and has cofounded and advised multiple startups.
Invests in
BiotechHealthtechMedical Devices
